One of the key shortcomings was that regulators lacked information about activity in the OTC derivatives market; this meant that risks could remain unnoticed until they materialised.
Ena od glavnih pomanjkljivosti je bilo dejstvo, da regulativni organi niso imeli informacij o aktivnosti na trgu izvedenih finančnih instrumentov OTC, zaradi česar so tveganja lahko ostala neopažena, vse dokler se niso uresničila.